Click for best price
Gene Therapy s Market Size, Share 2023
The global Gene Therapy Products market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Gene Therapy Products market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Gene Therapy Products market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Gene Therapy Products market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Products.
This report contains market size and forecasts of Gene Therapy Products in global, including the following market information:
- Global Gene Therapy Products Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Gene Therapy Products Market Sales, 2018-2023, 2024-2030, (K Units)
- Global top five Gene Therapy Products companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ex vivo Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy Products include Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapy Products manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy Products Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Gene Therapy Products Market Segment Percentages, by Type, 2022 (%)
Global Gene Therapy Products Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Gene Therapy Products Market Segment Percentages, by Application, 2022 (%)
- Cancer
- Monogenic
- Infectious disease
- Cardiovascular disease
- Other
Global Gene Therapy Products Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Gene Therapy Products Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Gene Therapy Products revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Gene Therapy Products revenues share in global market, 2022 (%)
- Key companies Gene Therapy Products sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Gene Therapy Products sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bluebird Bio
- Sangamo
- Spark Therapeutics
- Dimension Therapeutics
- Avalanche Bio
- Celladon
- Vical Inc.
- Advantagene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy Products, market overview.
Chapter 2: Global Gene Therapy Products market size in revenue and volume.
Chapter 3: Detailed analysis of Gene Therapy Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gene Therapy Products capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gene Therapy Products Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Products Overall Market Size
2.1 Global Gene Therapy Products Market Size: 2022 VS 2030
2.2 Global Gene Therapy Products Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Gene Therapy Products Sales: 2018-2030
3 Company Landscape
3.1 Top Gene Therapy Products Players in Global Market
3.2 Top Global Gene Therapy Products Companies Ranked by Revenue
3.3 Global Gene Therapy Products Revenue by Companies
3.4 Global Gene Therapy Products Sales by Companies
3.5 Global Gene Therapy Products Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gene Therapy Products Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gene Therapy Products Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gene Therapy Products Players in Global Market
3.8.1 List of Global Tier 1 Gene Therapy Products Companies
3.8.2 List of Global Tier 2 and Tier 3 Gene Therapy Products Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy Products Market Size Markets, 2022 & 2030
4.1.2 Ex vivo
4.1.3 In Vivo
4.2 By Type - Global Gene Therapy Products Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy Products Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy Products Revenue, 2024-2030
4.2.3 By Type - Global Gene Therapy Products Revenue Market Share, 2018-2030
4.3 By Type - Global Gene Therapy Products Sales & Forecasts
4.3.1 By Type - Global Gene Therapy Products Sales, 2018-2023
4.3.2 By Type - Global Gene Therapy Products Sales, 2024-2030
4.3.3 By Type - Global Gene Therapy Products Sales Market Share, 2018-2030
4.4 By Type - Global Gene Therapy Products Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy Products Market Size, 2022 & 2030
5.1.2 Cancer
5.1.3 Monogenic
5.1.4 Infectious disease
5.1.5 Cardiovascular disease
5.1.6 Other
5.2 By Application - Global Gene Therapy Products Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy Products Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy Products Revenue, 2024-2030
5.2.3 By Application - Global Gene Therapy Products Revenue Market Share, 2018-2030
5.3 By Application - Global Gene Therapy Products Sales & Forecasts
5.3.1 By Application - Global Gene Therapy Products Sales, 2018-2023
5.3.2 By Application - Global Gene Therapy Products Sales, 2024-2030
5.3.3 By Application - Global Gene Therapy Products Sales Market Share, 2018-2030
5.4 By Application - Global Gene Therapy Products Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Gene Therapy Products Market Size, 2022 & 2030
6.2 By Region - Global Gene Therapy Products Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy Products Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy Products Revenue, 2024-2030
6.2.3 By Region - Global Gene Therapy Products Revenue Market Share, 2018-2030
6.3 By Region - Global Gene Therapy Products Sales & Forecasts
6.3.1 By Region - Global Gene Therapy Products Sales, 2018-2023
6.3.2 By Region - Global Gene Therapy Products Sales, 2024-2030
6.3.3 By Region - Global Gene Therapy Products Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Gene Therapy Products Revenue, 2018-2030
6.4.2 By Country - North America Gene Therapy Products Sales, 2018-2030
6.4.3 US Gene Therapy Products Market Size, 2018-2030
6.4.4 Canada Gene Therapy Products Market Size, 2018-2030
6.4.5 Mexico Gene Therapy Products Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Gene Therapy Products Revenue, 2018-2030
6.5.2 By Country - Europe Gene Therapy Products Sales, 2018-2030
6.5.3 Germany Gene Therapy Products Market Size, 2018-2030
6.5.4 France Gene Therapy Products Market Size, 2018-2030
6.5.5 U.K. Gene Therapy Products Market Size, 2018-2030
6.5.6 Italy Gene Therapy Products Market Size, 2018-2030
6.5.7 Russia Gene Therapy Products Market Size, 2018-2030
6.5.8 Nordic Countries Gene Therapy Products Market Size, 2018-2030
6.5.9 Benelux Gene Therapy Products Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Gene Therapy Products Revenue, 2018-2030
6.6.2 By Region - Asia Gene Therapy Products Sales, 2018-2030
6.6.3 China Gene Therapy Products Market Size, 2018-2030
6.6.4 Japan Gene Therapy Products Market Size, 2018-2030
6.6.5 South Korea Gene Therapy Products Market Size, 2018-2030
6.6.6 Southeast Asia Gene Therapy Products Market Size, 2018-2030
6.6.7 India Gene Therapy Products Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Gene Therapy Products Revenue, 2018-2030
6.7.2 By Country - South America Gene Therapy Products Sales, 2018-2030
6.7.3 Brazil Gene Therapy Products Market Size, 2018-2030
6.7.4 Argentina Gene Therapy Products Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gene Therapy Products Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Gene Therapy Products Sales, 2018-2030
6.8.3 Turkey Gene Therapy Products Market Size, 2018-2030
6.8.4 Israel Gene Therapy Products Market Size, 2018-2030
6.8.5 Saudi Arabia Gene Therapy Products Market Size, 2018-2030
6.8.6 UAE Gene Therapy Products Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Bluebird Bio
7.1.1 Bluebird Bio Company Summary
7.1.2 Bluebird Bio Business Overview
7.1.3 Bluebird Bio Gene Therapy Products Major Product Offerings
7.1.4 Bluebird Bio Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.1.5 Bluebird Bio Key News & Latest Developments
7.2 Sangamo
7.2.1 Sangamo Company Summary
7.2.2 Sangamo Business Overview
7.2.3 Sangamo Gene Therapy Products Major Product Offerings
7.2.4 Sangamo Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.2.5 Sangamo Key News & Latest Developments
7.3 Spark Therapeutics
7.3.1 Spark Therapeutics Company Summary
7.3.2 Spark Therapeutics Business Overview
7.3.3 Spark Therapeutics Gene Therapy Products Major Product Offerings
7.3.4 Spark Therapeutics Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.3.5 Spark Therapeutics Key News & Latest Developments
7.4 Dimension Therapeutics
7.4.1 Dimension Therapeutics Company Summary
7.4.2 Dimension Therapeutics Business Overview
7.4.3 Dimension Therapeutics Gene Therapy Products Major Product Offerings
7.4.4 Dimension Therapeutics Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.4.5 Dimension Therapeutics Key News & Latest Developments
7.5 Avalanche Bio
7.5.1 Avalanche Bio Company Summary
7.5.2 Avalanche Bio Business Overview
7.5.3 Avalanche Bio Gene Therapy Products Major Product Offerings
7.5.4 Avalanche Bio Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.5.5 Avalanche Bio Key News & Latest Developments
7.6 Celladon
7.6.1 Celladon Company Summary
7.6.2 Celladon Business Overview
7.6.3 Celladon Gene Therapy Products Major Product Offerings
7.6.4 Celladon Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.6.5 Celladon Key News & Latest Developments
7.7 Vical Inc.
7.7.1 Vical Inc. Company Summary
7.7.2 Vical Inc. Business Overview
7.7.3 Vical Inc. Gene Therapy Products Major Product Offerings
7.7.4 Vical Inc. Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.7.5 Vical Inc. Key News & Latest Developments
7.8 Advantagene
7.8.1 Advantagene Company Summary
7.8.2 Advantagene Business Overview
7.8.3 Advantagene Gene Therapy Products Major Product Offerings
7.8.4 Advantagene Gene Therapy Products Sales and Revenue in Global (2018-2023)
7.8.5 Advantagene Key News & Latest Developments
8 Global Gene Therapy Products Production Capacity, Analysis
8.1 Global Gene Therapy Products Production Capacity, 2018-2030
8.2 Gene Therapy Products Production Capacity of Key Manufacturers in Global Market
8.3 Global Gene Therapy Products Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gene Therapy Products Supply Chain Analysis
10.1 Gene Therapy Products Industry Value Chain
10.2 Gene Therapy Products Upstream Market
10.3 Gene Therapy Products Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gene Therapy Products Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gene Therapy Products in Global Market
Table 2. Top Gene Therapy Products Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gene Therapy Products Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gene Therapy Products Revenue Share by Companies, 2018-2023
Table 5. Global Gene Therapy Products Sales by Companies, (K Units), 2018-2023
Table 6. Global Gene Therapy Products Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gene Therapy Products Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gene Therapy Products Product Type
Table 9. List of Global Tier 1 Gene Therapy Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Therapy Products Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Gene Therapy Products Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gene Therapy Products Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Gene Therapy Products Sales (K Units), 2018-2023
Table 15. By Type - Global Gene Therapy Products Sales (K Units), 2024-2030
Table 16. By Application ? Global Gene Therapy Products Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Gene Therapy Products Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gene Therapy Products Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Gene Therapy Products Sales (K Units), 2018-2023
Table 20. By Application - Global Gene Therapy Products Sales (K Units), 2024-2030
Table 21. By Region ? Global Gene Therapy Products Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Gene Therapy Products Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gene Therapy Products Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Gene Therapy Products Sales (K Units), 2018-2023
Table 25. By Region - Global Gene Therapy Products Sales (K Units), 2024-2030
Table 26. By Country - North America Gene Therapy Products Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gene Therapy Products Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Gene Therapy Products Sales, (K Units), 2018-2023
Table 29. By Country - North America Gene Therapy Products Sales, (K Units), 2024-2030
Table 30. By Country - Europe Gene Therapy Products Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gene Therapy Products Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Gene Therapy Products Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gene Therapy Products Sales, (K Units), 2024-2030
Table 34. By Region - Asia Gene Therapy Products Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gene Therapy Products Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Gene Therapy Products Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gene Therapy Products Sales, (K Units), 2024-2030
Table 38. By Country - South America Gene Therapy Products Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gene Therapy Products Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Gene Therapy Products Sales, (K Units), 2018-2023
Table 41. By Country - South America Gene Therapy Products Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Gene Therapy Products Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gene Therapy Products Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Gene Therapy Products Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gene Therapy Products Sales, (K Units), 2024-2030
Table 46. Bluebird Bio Company Summary
Table 47. Bluebird Bio Gene Therapy Products Product Offerings
Table 48. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bluebird Bio Key News & Latest Developments
Table 50. Sangamo Company Summary
Table 51. Sangamo Gene Therapy Products Product Offerings
Table 52. Sangamo Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sangamo Key News & Latest Developments
Table 54. Spark Therapeutics Company Summary
Table 55. Spark Therapeutics Gene Therapy Products Product Offerings
Table 56. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Spark Therapeutics Key News & Latest Developments
Table 58. Dimension Therapeutics Company Summary
Table 59. Dimension Therapeutics Gene Therapy Products Product Offerings
Table 60. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Dimension Therapeutics Key News & Latest Developments
Table 62. Avalanche Bio Company Summary
Table 63. Avalanche Bio Gene Therapy Products Product Offerings
Table 64. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Avalanche Bio Key News & Latest Developments
Table 66. Celladon Company Summary
Table 67. Celladon Gene Therapy Products Product Offerings
Table 68. Celladon Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Celladon Key News & Latest Developments
Table 70. Vical Inc. Company Summary
Table 71. Vical Inc. Gene Therapy Products Product Offerings
Table 72. Vical Inc. Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Vical Inc. Key News & Latest Developments
Table 74. Advantagene Company Summary
Table 75. Advantagene Gene Therapy Products Product Offerings
Table 76. Advantagene Gene Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Advantagene Key News & Latest Developments
Table 78. Gene Therapy Products Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Gene Therapy Products Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Gene Therapy Products Production by Region, 2018-2023 (K Units)
Table 81. Global Gene Therapy Products Production by Region, 2024-2030 (K Units)
Table 82. Gene Therapy Products Market Opportunities & Trends in Global Market
Table 83. Gene Therapy Products Market Drivers in Global Market
Table 84. Gene Therapy Products Market Restraints in Global Market
Table 85. Gene Therapy Products Raw Materials
Table 86. Gene Therapy Products Raw Materials Suppliers in Global Market
Table 87. Typical Gene Therapy Products Downstream
Table 88. Gene Therapy Products Downstream Clients in Global Market
Table 89. Gene Therapy Products Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gene Therapy Products Segment by Type in 2022
Figure 2. Gene Therapy Products Segment by Application in 2022
Figure 3. Global Gene Therapy Products Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapy Products Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gene Therapy Products Revenue, 2018-2030 (US$, Mn)
Figure 7. Gene Therapy Products Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gene Therapy Products Revenue in 2022
Figure 9. By Type - Global Gene Therapy Products Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Gene Therapy Products Revenue Market Share, 2018-2030
Figure 11. By Type - Global Gene Therapy Products Sales Market Share, 2018-2030
Figure 12. By Type - Global Gene Therapy Products Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Gene Therapy Products Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Gene Therapy Products Revenue Market Share, 2018-2030
Figure 15. By Application - Global Gene Therapy Products Sales Market Share, 2018-2030
Figure 16. By Application - Global Gene Therapy Products Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Gene Therapy Products Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Gene Therapy Products Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Gene Therapy Products Revenue Market Share, 2018-2030
Figure 20. By Region - Global Gene Therapy Products Sales Market Share, 2018-2030
Figure 21. By Country - North America Gene Therapy Products Revenue Market Share, 2018-2030
Figure 22. By Country - North America Gene Therapy Products Sales Market Share, 2018-2030
Figure 23. US Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Gene Therapy Products Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Gene Therapy Products Sales Market Share, 2018-2030
Figure 28. Germany Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 29. France Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Gene Therapy Products Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Gene Therapy Products Sales Market Share, 2018-2030
Figure 37. China Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 41. India Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Gene Therapy Products Revenue Market Share, 2018-2030
Figure 43. By Country - South America Gene Therapy Products Sales Market Share, 2018-2030
Figure 44. Brazil Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Gene Therapy Products Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Gene Therapy Products Sales Market Share, 2018-2030
Figure 48. Turkey Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Gene Therapy Products Revenue, (US$, Mn), 2018-2030
Figure 52. Global Gene Therapy Products Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Gene Therapy Products by Region, 2022 VS 2030
Figure 54. Gene Therapy Products Industry Value Chain
Figure 55. Marketing Channels
